We're thrilled to announce the national launch of our Better Me Provider (BMP) program! Neuronetics is the first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry. NeuroStar providers in the program are committed to rigorous standards, developed in collaboration with a network of TMS medical experts. Learn more about the BMP program and its remarkable success https://lnkd.in/gCfGhBhs #NeuroStar #MentalHealth #PatientCare
Neuronetics, Inc.
Medical Equipment Manufacturing
Malvern, PA 15,230 followers
Non-drug, safe, effective treatment for depression and other mental health conditions.
About us
Neuronetics, Inc., is the creator of NeuroStar Advanced Therapy, the market leader in Transcranial Magnetic Stimulation (TMS) for the treatment of Major Depressive Disorder and other mental health conditions. Based in Malvern, PA, we are a public medical device company (STIM) with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world. NeuroStar is the #1 TMS choice of doctors, with over 6.4 million treatments performed to date. It is an advanced treatment for depression and other mental health conditions. It is not medication, shock therapy, or surgery. NeuroStar is an outpatient treatment done in as little as 20 minutes for 36 sessions. It promotes neuroplasticity to target mental health where it starts — the brain. Neuronetics markets NeuroStar Advanced Therapy throughout the United States and select markets around the world. If you have questions or comments about NeuroStar, please e-mail us at customersupport@neurostar.com. For U.S. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207. Please visit NeuroStar.com/Safety for full safety and prescribing information.
- Website
-
http://www.NeuroStar.com
External link for Neuronetics, Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Malvern, PA
- Type
- Public Company
- Specialties
- TMS Therapy and transcranial magnetic stimulation
Locations
-
Primary
3222 Phoenixville Pike
Malvern, PA 19355, US
Employees at Neuronetics, Inc.
Updates
-
All NeuroStar Better Me Providers (BMP) commit to attending NeuroStar University (NSU). We are incredibly proud that NSU attendees showed 58% greater utilization when compared to practices that did not attend, translating to more patients receiving potentially life-changing treatment. Invest in your practice and your patients' well-being. Ask your NeuroStar representative about joining NeuroStar University today! #NeuroStar #TMS #Therapy #MentalHealth #Training #Patients #Results www.neurostar.com
-
-
Wondering what TMS therapy is all about? Watch our video and learn how NeuroStar TMS uses magnetic pulses to safely and effectively treat depression, anxiety that accompanies depression, and OCD. What questions do you have about TMS therapy? Leave a comment below! Visit NeuroStar.com or the link in bio to learn more. #TMStherapy #MentalHealthAwareness #NeuroStar
-
NeuroStar's Better Me Provider (BMP) pilot program is designed to set the standard for patient care in the industry. Ask a NeuroStar representative how it can make a difference in your practice today. #NeuroStar #MentalHealth #PatientCare
-
-
Thank you, Vogue, for raising awareness about adolescent depression and highlighting the potential of NeuroStar TMS treatment. With 42% of US high schoolers experiencing persistent sadness¹, NeuroStar TMS, a noninvasive procedure using magnetic fields to stimulate nerve cells in the brain, offers new hope with a 62% remission rate in depression symptoms.² FDA-cleared for adolescents aged 15 and up, it provides a promising alternative to medication. Learn more about NeuroStar TMS at NeuroStar.com and how it can help you or a loved one struggling with depression. #NeuroStarTMS #AdolescentMentalHealth #NeuroStarForAdolescents 1. Centers for Disease Control and Prevention. (2022). Youth Risk Behavior Survey Data Summary & Trends Report: 2011-2021. 2. FDA Clearance K231926 (2024). The outcomes reported represent the subset of study patients for which the CGI-S and GAD-7 data was reported before and after an acute course of NeuroStar TMS. Patients aged 12 to 21 (average 19.2 ± 1.5) were treated under real-world conditions where patients may have been prescribed concomitant depression treatments including medications. “Measurable relief” was defined as a CGI-S score ≤3 and “complete remission” was defined as a CGI-S score ≤2 at the end of treatment.
-
-
On Juneteenth, let's celebrate, learn, and grow, honoring the strength and resilience of the Black community. If you or someone you know is battling depression, reach out for help. NeuroStar TMS offers non-drug, non-invasive treatment, free from common systemic side effects of medication. Visit NeuroStar.com to find a NeuroStar TMS doctor near you. #NeuroStar #NeuroStarConnects #Juneteenth #NeuroStarSocial
-
Dads are strong, supportive, and often the rock of the family. But sometimes, even the strongest need help. This Father's Day, let's show the dads in our lives that it's okay to ask for help. Learn more about NeuroStar TMS therapy as a safe and effective treatment option for depression, depression with anxiety, and OCD. Visit NeuroStar.com #MensHealthMatters #NeuroStarTMS #FathersDay
-
Are you looking to transform the lives of more patients with NeuroStar? Our Better Me Provider (BMP) pilot program is designed to help you do just that. By following the 5-Standards, BMP providers are helping transform the lives of 3.6x more new patients with NeuroStar than non-program participants. To learn more about the program, contact a NeuroStar representative today. #NeuroStar #BetterMeProviders #MentalHealth
-
-
At Neuronetics, innovation goes beyond developing the most advanced TMS therapy. We're dedicated to advancing TMS clinical best practices through evidence based research. NeuroStar is proud to be showcased in six posters and one oral presentation at the Clinical TMS Society annual meeting with presenters Harold Sackeim, Dr. Linda Carpenter, Dr. John Luehr Sonder Behavioral Health & Wellness, Paul Croarkin, Kenny Pages, and Todd Hutton MD. Learn more about NeuroStar’s cutting edge research at the Clinical TMS Society annual meeting in our press release: https://lnkd.in/gWsqpuqU #NeuroStarTMS #TMSTherapy #MentalHealthInnovation #ClinicalExcellence
-
-
Don't ignore the signs. This #MensHealthMonth we're sharing these common warning signs of mental illness. If you recognize them in yourself or someone you care about, learn more about NeuroStar TMS by visiting NeuroStar.com #NeuroStar #MentalHealthMatters #MentalHealthAwareness #MentalHealthMatters